A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas
Open accessThe DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index; 4 of the 31 sources its claims cite were checked for support.
Abstract
Pheochromocytomas are neural crest-derived tumors that arise from inherited or sporadic mutations in at least six independent genes. The proteins encoded by these multiple genes regulate distinct functions. We show here a functional link between tumors with VHL mutations and those with disruption of the genes encoding for succinate dehydrogenase (SDH) subunits B (SDHB) and D (SDHD). A transcription profile of reduced oxidoreductase is detected in all three of these tumor types, together with an angiogenesis/hypoxia profile typical of VHL dysfunction. The oxidoreductase defect, not previously detected in VHL-null tumors, is explained by suppression of the SDHB protein, a component of mitochondrial complex II. The decrease in SDHB is also noted in tumors with SDHD mutations. Gain-of-function and loss-of-function analyses show that the link between hypoxia signals (via VHL) and mitochondrial signals (via SDH) is mediated by HIF1alpha. These findings explain the shared features of pheochromocytomas with VHL and SDH mutations and suggest an additional mechanism for increased HIF1alpha activity in tumors.
Overview
CoChat Summary
TL;DR
This study links pheochromocytomas with VHL mutations to those with SDHB or SDHD mutations through a shared hypoxia/angiogenesis and reduced oxidoreductase expression signature. It proposes a HIF1α–SDHB regulatory loop in which HIF1α suppresses SDHB, impairing mitochondrial complex II and further stabilizing HIF1α.
Key findings
- Unsupervised clustering of 76 primary pheochromocytomas/paragangliomas identified two dominant clusters: Cluster 1 contained all VHL and SDH tumors, while Cluster 2 contained all MEN2 and NF1 tumors; Cluster 1 included 12 of 13 extra-adrenal tumors, though more than half of Cluster 1 tumors were adrenal.
- Cluster 1 tumors showed a hypoxia/angiogenesis signature plus coordinated suppression of oxidoreductase enzymes; supervised predictors distinguished MEN2 from VHL and MEN2 from SDH tumors with extensive gene overlap, and over 92% of the cohort was correctly assigned to one of the two classes.
- SDHB protein was reduced in all tumors with SDH mutations and also suppressed in the majority of VHL-mutant and sporadic Cluster 1 tumors tested by immunoblot; SDHB immunostaining was highly concordant with immunoblot findings.
- In cell models, cobalt chloride reduced SDHB protein, expression of nondegradable HIF1αP402A/P564A downregulated SDHB, and HIF1α shRNA prevented cobalt chloride–induced SDHB reduction, supporting HIF1α-dependent SDHB regulation.
Methods
- Tumor specimens: 76 catecholamine-secreting pheochromocytomas or paragangliomas, including hereditary, familial undetermined, and sporadic tumors; 13 were extra-adrenal; no head/neck paragangliomas or SDHC-mutant tumors were included.
- Expression profiling: 84 tumor samples including six replicates were hybridized to Affymetrix U133A arrays; after excluding four poor-quality scans, 76 unique tumors were analyzed using dChip normalization, unsupervised hierarchical clustering, supervised k-nearest neighbor and weighted-voting models, and GSEA.
- Validation: DNA sequencing of RET, VHL, SDHD, SDHB, and SDHC in familial samples and 20 sporadic tumors; quantitative real-time PCR, Western blotting, immunohistochemistry, and cell-line experiments in HEK293, MPC 9/3L, and A2058 cells with cobalt chloride, HIF1α mutant, or HIF1α shRNA.
Limitations
- The paper states that limited tumor material prevented quantitation of HIF1α and HIF2α protein levels in primary samples.
- The paper states that HIF1α effects were less marked than those of hypoxia-mimetic agents, suggesting additional factors besides HIF1α may be involved in SDHB suppression, and that the precise mechanisms linking HIF1α and SDHB remain to be identified.
- The paper notes that long-term follow-up was not available to precisely define one VHL family as VHL type 2C; evident from the text, the series excluded head/neck paragangliomas and SDHC-mutant tumors, and only 20 sporadic tumors were sequenced.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 HIF1α Attenuates SDHB Levels (A) HIF1α expression was induced by treatment of mouse pheochromocytoma MPC 9/3L cells with 150 μM cobalt chloride for the indicated times. SDHB expression decreased in treated cells. Glut1 indicates increased activity of HIF1α, and β-actin was used as a loading control. (B) Transient expression in HEK293 cells of a HIF1α double mutant PA (P402A/P564A) that is resistant to VHL-mediated degradation reduced expression of SDHB. (C) A2058 cell lines stably expressing HIF1α shRNA do not show change in SDHB after cobalt chloride exposure, while SDHB is downregulated in control GFP shRNA cells treated with cobalt chloride. (D) Proposed model of HIF1α and SDHB interregulation. HIF1α downregulates SDHB, which leads to complex II dysfunction. High succinate levels resulting from loss of complex II, in turn, inhibit prolyl hydroxylase (PHD) activity [19]. Non-hydroxylated HIF1α is resistant to VHL-mediated targeting for degradation and can therefore activate downstream genes, such as angiogenic factors. “E3 complex” indicates the E3 ubiquitin ligase complex for which VHL is the substrate recognition factor.](https://figures.cochat.ai/paper-figures/7338e6f619eb44a99d4e1429a6a07626/a-hif1-regulatory-loop-links-hypoxia-and-mitochondrial-signals-in-figure-4.jpg)
Verification
Claims the paper makes
2 Valid · 1 Not valid · 19 Not checked · 72 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“The two prototype genes of Cluster 2 (RET and NF1) are linked by their common ability to activate the RAS/RAF/MAP kinase signaling cascade [16,17].”
§ A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas > Results > Suppressed SDHB Expression Is a Common Feature of VHL and SDH Tumors
What the sources say
- Disputedcites [16] 1990, The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins., Cell sourceExperimental — accuracy not yet measured
The Abstract (page not supplied) reports that an NF1 segment inhibits both wild-type and activated H-ras in yeast, contrary to the claim that NF1 activates the signaling cascade. The paper establishes a functional link between NF1 and RAS, but it does not report that NF1 and RET share an ability to activate a RAS/RAF/MAP kinase cascade. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [17] 2000, Signaling through Ras is essential for ret oncogene-induced cell differentiation in PC12 cells., J Biol Chem sourceExperimental — accuracy not yet measured
The paper reports that active RET mutants trigger Ras signaling in PC12 cells, and its discussion links RET to the Ras/MAP kinase pathway (Discussion; page not provided). It does not address NF1, so it cannot establish the claimed common ability of RET and NF1 to activate the cascade. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Mitochondrial complex II is a component of the electron transport chain, and mutations of SDHB or SDHD genes that abrogate the oxidoreductase function of complex II can cause pheochromocytomas [9,14,15].”
§ A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas > Results > Suppressed SDHB Expression Is a Common Feature of VHL and SDH Tumors
What the sources say
- Partly supportedcites [9] 2001, The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway., Am J Hum Genet sourceExperimental — accuracy not yet measured
Our copy squarely supports the SDHD branch: the Results (Enzyme-Function Studies) and Abstract report that the R22X SDHD mutation with maternal LOH gave 'a complete and selective loss of complex II enzymatic activity in the inherited pheochromocytoma', and the Discussion links that defect to angiogenic-factor overproduction and tumour growth (though hedged: 'probably involved … possibly in tumor development', 'unclear whether the activation of hypoxia pathways is or is not sufficient to induce tumorigenesis by itself'). The SDHB branch is not this paper's finding: the Introduction only credits 'inactivating SDHB gene mutations … detected in two kindreds' to Astuti et al. 2001b, without measuring complex II activity or specifying pheochromocytoma for SDHB. So only half of the disjunctive claim, plus its causal strength, is carried by this source. (LLM, conf=0.70)
- Not checked yetcites [14] 2002, Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma., J Clin Endocrinol Metab source
- Not checked yetcites [15] 2003, Architecture of succinate dehydrogenase and reactive oxygen species generation., Science source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These clinical observations and the finding of increased expression of HIF targets in tumors with SDH mutations [9,10] have suggested the possibility that the VHL and SDH syndromes intersect at the molecular level.”
§ A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas > Introduction
What the sources say
- Partly supportedcites [9] 2001, The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway., Am J Hum Genet sourceExperimental — accuracy not yet measured
Our copy fully supports the HIF-target half of the sentence: the Abstract reports VEGF and EPAS1/HIF2α mRNA three- and sixfold higher in the SDHD-mutant (R22X) pheochromocytoma than in sporadic controls, the Results (fig. 7) give the Mann-Whitney statistics for that increase, and the Discussion describes 'strong expression of hypoxia-inducible transcription factors (EPAS1/HIF2α and HIF1α) and genes encoding some of the targets of these factors' in the paragangliomas, alongside the family's clinical observations. What the source does not contain is the convergence with VHL: searches for 'VHL', 'von Hippel-Lindau' and oxygen-sensing comparisons returned no passage in which this paper links SDH to the VHL syndrome or pathway — its stated conclusion is only that complex II loss is 'associated with a high expression of angiogenic factors' and that it remains 'unclear whether the activation of hypoxia pathways is or is not sufficient to induce tumorigenesis'. The assertion that the VHL and SDH syndromes intersect at the molecular level is therefore the citing authors' inference, not a point this paper makes. (LLM, conf=0.68)
- Not checked yetcites [10] 2003, Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas., Cancer Res
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found that the expression of SDHB is reduced in all tumors with SDH (both SDHB and SDHD) mutations in this cohort (Figure 3A)”
§ A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas > Results > Suppressed SDHB Expression Is a Common Feature of VHL and SDH Tumors
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In two cell line models, HEK293 and mouse pheochromocytoma cell line (MPC) 9/3L, exposure to the hypoxia-mimetic agent cobalt chloride reduced SDHB protein expression (Figure 4A).”
§ A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas > Results > HIF1α Contributes to SDHB Regulation
plainstates a causen = 2- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
50 more claims
Create a free account to see all 94 claims and to verify the 27 references still open.
- It may state two separate claims as one. 19
- Probably not a substantial claim. 29
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, the HIF1α transcription factor accumulates in SDH and FH mutant tumors, presumably due to inhibition of the EglN prolyl hydroxylases (Dahia et al., 2005; Isaacs et al., 2005; Pollard et al., 2005, 2007; Selak et al., 2005).”
From Influence of Metabolism on Epigenetics and Disease (2013) · cites this paper as Dahia et al., 2005
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In addition, patients harbouring mutations in SDH have increased HIF-1α activity23,24 and circulating succinate25.”
From Succinate is an inflammatory signal that induces IL-1β through HIF-1α (2013) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas > Results > Suppressed SDHB Expression Is a Common Feature of VHL and SDH Tumors
“lanes 5–7”
§ A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas > Results > Suppressed SDHB Expression Is a Common Feature of VHL and SDH Tumors
“tumors 16, 85, 101, and 152, respectively”
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184 · cited 1×
“Gene filtering and hierarchical clustering analysis were also performed in dChip [29].”
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197 · cited 1×
“To gather insights into the function of genes associated with the clusters defined by the comparisons described above, we used a statistical method designed to test for the enrichment of groups of genes in data generated from expression studies, GSEA [”
MethodJaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection.
Li, C., & Wong, W. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.31 · Cited by 3,133 · cited 1×
“The reliability of the clusters was verified by a resampling method based on the standard errors for expression values [30].”
Self-citationSuccinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108 · cited 1×
“(D) Proposed model of HIF1α and SDHB interregulation. HIF1α downregulates SDHB, which leads to complex II dysfunction. High succinate levels resulting from loss of complex II, in turn, inhibit prolyl hydroxylase (PHD) activity [”
BackgroundMLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
Armstrong, S. A., Staunton, J. E., Silverman, L. B., Pieters, R., den Boer, M. L., Minden, M. D., Sallan, S. E., Lander, E. S., Golub, T. R., & Korsmeyer, S. J. (2002) · Nature Genetics · doi:10.1038/ng765 · Cited by 1,723
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · cited 1×
“encode subunits of SDH, the enzyme that composes mitochondrial complex II [”
Kanellopoulou, C., Muljo, S. A., Kung, A. L., Ganesan, S., Drapkin, R., Jenuwein, T., Livingston, D. M., & Rajewsky, K. (2005) · Genes & Development · doi:10.1101/gad.1248505 · Cited by 1,254
Self-citationAstuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087 · cited 2×
“Direct sequencing of familial samples and 20 sporadic tumors was performed from tumor and germline DNA, whenever available, using PCR products that encompass exons and intron–exon boundaries of RET (exons 10, 11, and 13–16), VHL (exons 1–3), SDHD (exons 1–4), and SDHB (exons 1–8), as previously described [7,37,38].”
MethodSelf-citationMasson, N., Willam, C., Maxwell, P. H., Pugh, C. W., & Ratcliffe, P. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.18.5197 · Cited by 1,014 · cited 1×
“A). A HIF1α double mutant (P402A/P564A) that is resistant to VHL-mediated proteasome degradation [”
BackgroundArchitecture of succinate dehydrogenase and reactive oxygen species generation
Yankovskaya, V., Horsefield, R., Törnroth, S., Luna-Chavez, C., Miyoshi, H., Léger, C., Byrne, B., Cecchini, G., & Iwata, S. (2003) · Science · doi:10.1126/science.1079605 · Cited by 927
Mootha, V. K., Bunkenborg, J., Olsen, J. V., Hjerrild, M., Wisniewski, J. R., Stahl, E., Bolouri, M. S., Ray, H. N., Sihag, S., Kamal, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00926-7 · Cited by 889 · cited 1×
“com); manually curated proteome datasets were also used [34–36].”
Molecular basis of the VHL hereditary cancer syndrome
Kaelin, W. G. (2002) · Nature Reviews Cancer · doi:10.1038/nrc885 · Cited by 865 · cited 1×
“gene, whose product is a known regulator of the activity of the HIF pathway [”
BackgroundSignal transduction to hypoxia-inducible factor 1
Semenza, G. L. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01168-1 · Cited by 860
The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins.
Ballester, R., Marchuk, D., Boguski, M., Saulino, A., Letcher, R., Wigler, M., & Collins, F. (1990) · Cell · doi:10.1016/0092-8674(90)90151-4 · Cited by 847 · cited 1×
“are linked by their common ability to activate the RAS/RAF/MAP kinase signaling cascade [”
BackgroundInhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
Kondo, K., Klco, J., Nakamura, E., Lechpammer, M., & Kaelin, W. G. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00043-0 · Cited by 761
A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes.
Ishii, N., Fujii, M., Hartman, P. S., Tsuda, M., Yasuda, K., Senoo-Matsuda, N., Yanase, S., Ayusawa, D., & Suzuki, K. (1998) · Nature · doi:10.1038/29331 · Cited by 687 · cited 1×
“dysfunction [22–24].”
Yuan, Y., Hilliard, G., Ferguson, T., & Millhorn, D. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300463200 · Cited by 638 · cited 1×
“]. HEK293 cells were cultured in DMEM and 10% fetal bovine serum supplemented with 100 U/ml penicillin and 100 μg/ml streptomycin. HIF1α expression was induced in MPC 9/3L or HEK293 cells by treatment with 150 μM cobalt chloride, which blocks prolyl hydroxylation of HIF1α and its binding to VHL [”
MethodInhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth
Kondo, K., Kim, W. Y., Lechpammer, M., & Kaelin, W. G. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000083 · Cited by 611
Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.
Gimenez‐Roqueplo, A., Favier, J., Rustin, P., Rieubland, C., Crespin, M., Nau, V., Kien, P. K. V., Corvol, P. L., Plouin, P., & Jeunemaître, X. (2003) · PubMed · Cited by 609
Scortegagna, M., Ding, K., Oktay, Y., Gaur, A., Thurmond, F., Yan, L.-J., Marck, B. T., Matsumoto, A. M., Shelton, J. M., Richardson, J. A., et al. (2003) · Nature Genetics · doi:10.1038/ng1266 · Cited by 496 · cited 1×
“and in keeping with our current data, HIF2a /EPAS1-null mice were reported to have increased SDH activity in muscle [25].”
Rajasekhar, V. K., Viale, A., Socci, N. D., Wiedmann, M., Hu, X., & Holland, E. C. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00395-2 · Cited by 420 · cited 1×
“Activated RAS signaling has been shown by expression profiling to be associated with increased translation events [18].”
An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis.
Sweet-Cordero, A., Mukherjee, S., Subramanian, A., You, H., Roix, J. J., Ladd-Acosta, C., Mesirov, J., Golub, T. R., & Jacks, T. (2005) · Nature Genetics · doi:10.1038/ng1490 · Cited by 414 · cited 1×
“-Values are adjusted to account for multiple hypothesis testing [”
MethodVanharanta, S., Buchta, M., McWhinney, S. R., Virta, S. K., Peçzkowska, M., Morrison, C. D., Lehtonen, R., Januszewicz, A., Järvinen, H., Juhola, M., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/381054 · Cited by 389 · cited 4×
“Also, clinical similarities besides pheochromocytoma have been noted in families with germline mutations of VHL and SDHB [26].”
InfluentialHoffman, M. A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.10.1019 · Cited by 382 · cited 1×
“). These features are suggestive of VHL type 2C, which has been deemed HIF-independent [”
BackgroundClifford, S. C. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.10.1029 · Cited by 373
Gimenez-Roqueplo, A.-P., Favier, J., Rustin, P., Mourad, J.-J., Plouin, P.-F., Corvol, P., Rötig, A., & Jeunemaitre, X. (2001) · The American Journal of Human Genetics · doi:10.1086/324413 · Cited by 364 · cited 3×
“SDH mutations [9,10] have suggested the possibility that the”
Schadt, E. E., Li, C., Ellis, B., & Wong, W. H. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10073 · Cited by 288
Dahia, P. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.2.185 · Cited by 274
Self-citationIshii, T., Yasuda, K., Akatsuka, A., Hino, O., Hartman, P. S., & Ishii, N. (2005) · Cancer Research · doi:10.1158/0008-5472.203.65.1 · Cited by 253 · cited 1×
“dysfunction [22–24].”
Pheochromocytoma: The expanding genetic differential diagnosis.
Bryant, J., Farmer, J., Kessler, L. J., Townsend, R. R., & Nathanson, K. L. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg024 · Cited by 250 · cited 1×
“Pheochromocytomas can arise as a result of mutations in the following disease-associated genes: RET in multiple endocrine neoplasia type 2 (MEN2); VHL in von Hippel-Lindau disease (VHL); NF1 in neurofibromatosis type 1 (NF1); and succinate dehydrogenase (SDH) subunits B, C, or D in familial paraganglioma syndromes typ…”
InfluentialFunctional Consequences of a SDHB Gene Mutation in an Apparently Sporadic Pheochromocytoma
Gimenez-Roqueplo, A.-P., Favier, J., Rustin, P., Rieubland, C., Kerlan, V., Plouin, P.-F., Rötig, A., & Jeunemaitre, X. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020525 · Cited by 209 · cited 1×
“Mitochondrial complex II is a component of the electron transport chain, and mutations of SDHB or SDHD genes that abrogate the oxidoreductase function of complex II can cause pheochromocytomas [9,14,15].”
Eng, C., Crossey, P. A., Mulligan, L. M., Healey, C. S., Houghton, C., Prowse, A., Chew, S. L., Dahia, P. L., O'Riordan, J. L., & Toledo, S. P. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.12.934 · Cited by 172 · cited 1×
“Direct sequencing of familial samples and 20 sporadic tumors was performed from tumor and germline DNA, whenever available, using PCR products that encompass exons and intron–exon boundaries of RET (exons 10, 11, and 13–16), VHL (exons 1–3), SDHD (exons 1–4), and SDHB (exons 1–8), as previously described [7,37,38].”
MethodSelf-citationBishop, T., Lau, K. W., Epstein, A. C. R., Kim, S. K., Jiang, M., O'Rourke, D., Pugh, C. W., Gleadle, J. M., Taylor, M. S., Hodgkin, J., et al. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020289 · Cited by 145
Progress in understanding structure-function relationships in respiratory chain complex II.
Ackrell, B. A. C. (2000) · FEBS Letters · doi:10.1016/s0014-5793(99)01749-4 · Cited by 144 · cited 1×
“]. This enzyme is both a component of the Krebs cycle, by oxidizing succinate to fumarate, and of the mitochondrial respiratory chain, by transferring electrons to the ubiquinone pool [”
Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice
Powers, J. F., EVINGER, M. J. Q., Tsokas, P., Bedri, S., Alroy, J., Shahsavari, M., & Tischler, A. S. (2000) · Cell and Tissue Research · doi:10.1007/s004410000290 · Cited by 144
Self-citationManger, W. M., & Gifford, R. W. (2002) · The Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2002.01452.x · Cited by 143
The von Hippel-Lindau gene, kidney cancer, and oxygen sensing.
Kaelin, W. G. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000092803.69761.41 · Cited by 135 · cited 1×
“tumor suppressor is a key mediator of the hypoxia response. It targets the hypoxia-inducible factor 1 subunit α (HIF1α) for ubiquitin-mediated degradation under normal oxygen conditions [”
BackgroundGuo, J., & Lemire, B. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306312200 · Cited by 103 · cited 1×
“dysfunction [22–24].”
Douwes Dekker, P., Hogendoorn, P., Kuipers‐Dijkshoorn, N., Prins, F., van Duinen, S., Taschner, P., van der Mey, A., & Cornelisse, C. (2003) · The Journal of Pathology · doi:10.1002/path.1461 · Cited by 94
Signaling through Ras Is Essential for retOncogene-induced Cell Differentiation in PC12 Cells
Califano, D., Rizzo, C., D'Alessio, A., Colucci-D'Amato, G. L., Calı̀, G., Bartoli, P. C., Santelli, G., Vecchio, G., & de Franciscis, V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m905866199 · Cited by 67
Aguiar, R. C. T., Cox, G., Pomeroy, S. L., & Dahia, P. L. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7547 · Cited by 50 · cited 1×
“Direct sequencing of familial samples and 20 sporadic tumors was performed from tumor and germline DNA, whenever available, using PCR products that encompass exons and intron–exon boundaries of RET (exons 10, 11, and 13–16), VHL (exons 1–3), SDHD (exons 1–4), and SDHB (exons 1–8), as previously described [7,37,38].”
MethodAguiar, R. C. T. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.6.2890 · Cited by 38
Cited by
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
“In fact, there may be several levels of adaptive response and feedback-feedforward cycles such as the recently reported downregulation of succinate dehydrogenase by hypoxia (Dahia et al., 2005).”
BackgroundInfluence of Metabolism on Epigenetics and Disease
Kaelin, W. G., & McKnight, S. L. (2013) · Cell · doi:10.1016/j.cell.2013.03.004 · Cited by 920
“For example, the HIF1a transcription factor accumulates in SDH and FH mutant tumors, presumably due to inhibition of the EglN prolyl hydroxylases (Dahia et al., 2005; Isaacs et al., 2005; Pollard et al., 2005, 2007; Selak et al., 2005).”
SDH mutations establish a hypermethylator phenotype in paraganglioma
Letouzé, E., Martinelli, C., Loriot, C., Burnichon, N., Abermil, N., Ottolenghi, C., Janin, M., Menara, M., Nguyen, A. T., Benit, P., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.04.018 · Cited by 776
“To date, the only mechanism linking SDH to cancer involves hypoxia-inducible factors (HIFs) (Dahia et al., 2005; GimenezRoqueplo et al., 2001).”
BackgroundComprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
Fishbein, L., Leshchiner, I., Walter, V., Danilova, L., Robertson, A. G., Johnson, A. R., Lichtenberg, T. M., Murray, B. A., Ghayee, H. K., Else, T., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.01.001 · Cited by 789
“Germline mutations in SDHB , SDHD , and VHL , and somatic mutations in VHL and EPAS1 were completely specific to this subtype (Figure 5A), consistent with earlier studies (Burnichon et al., 2011; Dahia et al., 2005; We-lander et al., 2014).”
Self-citation
Metadata
- Authors
- Dahia, P. L. M., Ross, K. N., Wright, M. E., Hayashida, C. Y., Santagata, S., Barontini, M., Kung, A. L., Sanso, G., Powers, J. F., Tischler, A. S., Hodin, R., Heitritter, S., Moore, F., Dluhy, R., Sosa, J. A., Ocal, I. T., Benn, D. E., Marsh, D. J., Robinson, B. G., Schneider, K., Garber, J., Arum, S. M., Korbonits, M., Grossman, A., Pigny, P., Toledo, S. P. A., Nosé, V., Li, C., & Stiles, C. D.
- Affiliations
- Harvard University (US)
- Broad Institute (US)
- Universidade de São Paulo (BR)
- Brigham and Women's Hospital (US)
- Hospital General de Niños Ricardo Gutierrez (AR)
- Tufts University (US)
- Yale University (US)
- The University of Sydney (AU)
- Boston University (US)
- St Bartholomew's Hospital (GB)
- Université de Lille (FR)
- Corresponding author
- Dahia, Patricia L. M
- ORCID
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2005-07-25
- Volume
- 1
- Issue
- 1
- Pages
- e8
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC1183527
- OpenAlex
- W2093711185
- Semantic Scholar
- 95012d4d3ac3f080e7e5247a25cf9caa2d5312a5
- Cited by
- 443
- References
- 46
- Citations by year
- 2026: 10 · 2025: 7 · 2024: 14 · 2023: 15 · 2022: 17 · 2021: 11 · 2020: 24 · 2019: 19 · 2018: 20 · 2017: 30 · 2016: 18 · 2015: 34 · 2014: 34 · 2013: 36 · 2012: 26
- FWCI
- 17.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- UTS ePRESS (University of Technology Sydney) (submittedVersion, other-oa)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion, cc-by)
- Funders
- Dana Foundation
- Massachusetts General Hospital
- National Institutes of Health (CA48017, HD 24926)
- National Cancer Institute (R01CA048017)
- National Institute of Neurological Disorders and Stroke (R01NS037685)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Keywords
- pheochromocytoma, HIF-1α, hypoxia, mitochondrial signaling, succinate dehydrogenase, SDHB, SDHD, VHL mutation, tumor angiogenesis, neural crest-derived tumors, transcriptional regulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.